|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-4-1
|
|
pubmed:abstractText |
Weight gain, leading to further morbidity and poor treatment adherence, is a common consequence of treatment with antipsychotic drugs. A recent study showed that a polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene is associated with antipsychotic-induced weight gain. The authors determined whether this association held true for weight gain after clozapine treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0002-953X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
160
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
677-9
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:12668355-Antipsychotic Agents,
pubmed-meshheading:12668355-Body Mass Index,
pubmed-meshheading:12668355-China,
pubmed-meshheading:12668355-Clozapine,
pubmed-meshheading:12668355-Female,
pubmed-meshheading:12668355-Genetic Predisposition to Disease,
pubmed-meshheading:12668355-Genotype,
pubmed-meshheading:12668355-Humans,
pubmed-meshheading:12668355-Male,
pubmed-meshheading:12668355-Phenotype,
pubmed-meshheading:12668355-Polymorphism, Genetic,
pubmed-meshheading:12668355-Promoter Regions, Genetic,
pubmed-meshheading:12668355-Receptors, Serotonin,
pubmed-meshheading:12668355-Schizophrenia,
pubmed-meshheading:12668355-Sex Factors,
pubmed-meshheading:12668355-Weight Gain
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Polymorphism of the promoter region of the serotonin 5-HT(2C) receptor gene and clozapine-induced weight gain.
|
|
pubmed:affiliation |
Department of Biomedical Science, University of Sheffield, UK. g.p.reynolds@sheffield.ac.uk
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
